![David Crean](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Crean
Corporate Officer/Principal chez
MEDICINOVA, INC.
Fortune : - $ au 30/06/2026
Profil
David H.
Crean is the founder of Cardiff Advisory LLC, founded in 2021, where the title held is Managing Partner.
Current jobs include President & Chief Executive Officer at Coast Bioventures LLC; Chairman & President at Alzheimer's Association Northern California & Northern Nevada; Director at Association for Corporate Growth of Orange County; Independent Director at Paracrine, Inc. since 2022; Director at Almon Therapeutics, Inc.; Director at Cenna Biosciences, Inc. since 2023; Director at Biocom California since 2022; Chief Business Officer at MediciNova, Inc. since 2021; Member at Securities Investor Protection Corp.; Member at Corporate Directors Forum; Member at Financial Industry Regulatory Authority, Inc.; Partner at Mesa Verde Venture Partners LP; and Venture Partner at VU Venture Partners since 2024.
Former jobs include Chief Executive Officer & Director at Talapo Therapeutics, Inc. from 2018 to 2020; President & Chief Executive Officer at Boys & Girls Clubs of San Dieguito from 2013 to 2015; Director at Histogen, Inc. from 2018 to 2020; Director at Phoenix Molecular Designs Ltd. from 2021 to 2022; Managing Director at Objective Capital Partners LLC from 2015 to 2022; Director at California Life Sciences Association from 2018 to 2024; Independent Director at Histogen, Inc. from 2023 to 2024; Vice President-Corporate Development at Almirall LLC; and Member-Governors Board at Biocom, Inc. Education includes undergraduate degree from Canisius College; graduate and doctorate degrees from State University of New York at Buffalo; and MBAistration from Pepperdine Graziadio Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MEDICINOVA, INC. -.--% | 24/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de David Crean
| Sociétés | Poste | Début |
|---|---|---|
| MEDICINOVA, INC. | Corporate Officer/Principal | 01/05/2021 |
Corporate Directors Forum
 Corporate Directors Forum Miscellaneous Commercial ServicesCommercial Services Operates as corporate directors forum | Corporate Officer/Principal | - |
Cenna Biosciences, Inc.
 Cenna Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drugs for Alzheimer's disease | Directeur/Membre du Conseil | 01/12/2023 |
VU Venture Partners
 VU Venture Partners Investment ManagersFinance VU Venture Partners invests in companies located across the globe, primarily in the United States. The firm focuses on consumer, enterprise, fintech, frontier, healthcare, and property technology. It provides financing for pre-seed, seed, and early-stage capital requirements with an investment of USD 0.2 - 1 million. The firm acts as a lead investor, considers co-investments and makes follow-on investments. | Private Equity Investor | 01/04/2024 |
Mesa Verde Venture Partners LP
 Mesa Verde Venture Partners LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | - |
Securities Investor Protection Corp.
 Securities Investor Protection Corp. Insurance Brokers/ServicesFinance Provides industry financed insurance plan services | Corporate Officer/Principal | - |
Financial Industry Regulatory Authority, Inc.
 Financial Industry Regulatory Authority, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization that focuses on governing activities of all broker-dealer firms and brokers | Corporate Officer/Principal | - |
Paracrine, Inc.
 Paracrine, Inc. BiotechnologyHealth Technology Develops autologous, device-based cell therapy platform focused on vascular, immune and inflammatory conditions | Directeur/Membre du Conseil | 12/05/2022 |
Alzheimer's Association Northern California & Northern Nevada | Président | - |
| ░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░ ░░ ░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de David Crean
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de David Crean
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
MediciNova, Inc.
 MediciNova, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which develops novel therapeutics for the treatment of neurological and other disorders | Health Technology |
Almirall LLC
 Almirall LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products for skin disorders | Health Technology |
Canisius College
 Canisius College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Buffalo
 State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Commercial Services |
Securities Investor Protection Corp.
Securities Investor Protection Corp. Insurance Brokers/ServicesFinance Provides industry financed insurance plan services | Finance |
Corporate Directors Forum
Corporate Directors Forum Miscellaneous Commercial ServicesCommercial Services Operates as corporate directors forum | Commercial Services |
Financial Industry Regulatory Authority, Inc.
Financial Industry Regulatory Authority, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization that focuses on governing activities of all broker-dealer firms and brokers | Commercial Services |
Association for Corporate Growth of Orange County | |
Histogen, Inc. /Old/
 Histogen, Inc. /Old/ Medical/Nursing ServicesHealth Services Researches, develops, manufactures and sells medicines | Health Services |
Mesa Verde Venture Partners LP
Mesa Verde Venture Partners LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Alzheimer's Association Northern California & Northern Nevada | |
Objective Capital Partners LLC
 Objective Capital Partners LLC Investment ManagersFinance Engages in mergers and acquisitions advisory | Finance |
Talapo Therapeutics, Inc.
 Talapo Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular approaches to treat obesity | Health Technology |
Phoenix Molecular Designs Ltd.
 Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs to treat triple negative breast cancer | Commercial Services |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
Pepperdine Graziadio Business School
 Pepperdine Graziadio Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Histogen, Inc.
 Histogen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage therapeutics company that develops potential clinical and preclinical drugs | Health Technology |
Boys & Girls Clubs of San Dieguito | |
Coast Bioventures LLC | |
Cardiff Advisory LLC | |
Cenna Biosciences, Inc.
Cenna Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drugs for Alzheimer's disease | Commercial Services |
Paracrine, Inc.
Paracrine, Inc. BiotechnologyHealth Technology Develops autologous, device-based cell therapy platform focused on vascular, immune and inflammatory conditions | Health Technology |
VU Venture Partners
VU Venture Partners Investment ManagersFinance VU Venture Partners invests in companies located across the globe, primarily in the United States. The firm focuses on consumer, enterprise, fintech, frontier, healthcare, and property technology. It provides financing for pre-seed, seed, and early-stage capital requirements with an investment of USD 0.2 - 1 million. The firm acts as a lead investor, considers co-investments and makes follow-on investments. | Finance |
